• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Amphetamines and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenethylamines Amphetamines and derivatives

Latest Research Briefing on Chemical-Biopharmaceutical Innovations: Focus on 152477-88-8 and (+/-)-Methamphetamine-d11

In recent years, the chemical-biopharmaceutical field has witnessed significant advancements in the synthesis and application of specialized compounds, particularly those used in forensic and clinical research. Among these, the compound with CAS number 152477-88-8 and the deuterated analog (+/-)-methamphetamine-d11 have garnered attention due to their critical roles in analytical methodologies and drug metabolism studies. This briefing synthesizes the latest research findings on these compounds, highlighting their applications, synthesis pathways, and implications for future research.

The compound 152477-88-8, a precursor in the synthesis of various pharmacologically active molecules, has been the subject of recent studies focusing on its stability and reactivity under different conditions. Researchers have explored its potential in the development of novel therapeutic agents, leveraging its unique chemical properties to enhance drug efficacy and reduce side effects. Concurrently, (+/-)-methamphetamine-d11, a deuterium-labeled version of methamphetamine, has been extensively used as an internal standard in mass spectrometry-based assays, enabling precise quantification of methamphetamine and its metabolites in biological samples.

Recent publications have detailed innovative synthetic routes for 152477-88-8, emphasizing green chemistry principles to minimize environmental impact. These studies have demonstrated improved yields and purity, which are crucial for scaling up production for clinical and research purposes. On the other hand, (+/-)-methamphetamine-d11 has been employed in cutting-edge pharmacokinetic studies, providing insights into the drug's absorption, distribution, metabolism, and excretion (ADME) profiles. Such studies are invaluable for understanding the pharmacodynamics of methamphetamine and developing strategies to mitigate its abuse potential.

One notable study published in the Journal of Analytical Toxicology utilized (+/-)-methamphetamine-d11 to validate a highly sensitive LC-MS/MS method for detecting methamphetamine in hair samples. The deuterated compound's isotopic purity and stability were critical in achieving low detection limits and high accuracy, underscoring its importance in forensic toxicology. Additionally, research on 152477-88-8 has revealed its potential as a scaffold for designing inhibitors targeting specific enzymes involved in neurodegenerative diseases, opening new avenues for drug discovery.

In conclusion, the ongoing research on 152477-88-8 and (+/-)-methamphetamine-d11 underscores their versatility and significance in both analytical and therapeutic contexts. Future studies are expected to further elucidate their mechanisms of action and explore novel applications, particularly in personalized medicine and addiction treatment. This briefing serves as a foundation for researchers and industry professionals seeking to stay abreast of the latest developments in this dynamic field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)